In their study, researchers identified a high proportion (≥15%) of activated CTLs in biopsy specimens from patients with Hodgkin’s disease and ALK-negative anaplastic large cell lymphoma (ALCL), which correlated with poorer OS and PFS (89). The gene discussed is ALK; the disease is anaplastic large cell lymphoma.